[ad_1]
The LSF joins PsyMed Ventures in offering grants for initiatives exploring synergies between psychedelics and longevity.
Nov. 4, 2022 — Miami — The Longevity Science Basis, a nonprofit group devoted to funding analysis establishing an extended and more healthy human lifespan, introduced a brand new funding name for psychedelics analysis throughout at this time’s Miami Wonderland occasion. The funding name is a joint effort between the Longevity Science Basis and PsyMed Ventures, an early-stage fund investing in frontier psychological well being applied sciences.
Whereas not sometimes mentioned as such, psychological and mind well being are essential elements of human longevity. Psychedelic functions for psychological well being therapies are quickly accelerating, with compounds like ketamine, MDMA and psilocybin exhibiting promising ends in treating post-traumatic stress dysfunction, melancholy and dependancy. Researchers have additionally confirmed ketamine and psilocybin will help regrow neural connections, a doubtlessly groundbreaking discovering in creating future therapies for aging-related neurodegenerative illnesses.
The funding name invitations anybody on the forefront of the cutting-edge longevity and psychedelic fields to submit grant-funded proposals. The LSF and PsyMed particularly encourage functions from researchers engaged on initiatives associated to utilizing current or novel psychedelics to handle, delay or reverse age-associated psychological and mind illnesses. In addition they are smitten by proposals on mechanisms behind the advanced results elicited by psychedelic compounds and another breakthrough areas synergizing the longevity and psychedelics fields.
“Psychological well being is a crucial but usually underlooked facet of longevity — I imagine a wholesome thoughts is equally as necessary as a wholesome physique,” stated Garri Zmudze, government coordinator of the Longevity Science Basis. “By funding analysis on psychedelics, the Longevity Science Basis is contributing to a physique of information remodeling mind well being and longevity.”
“There’s unbelievable innovation occurring within the improvement of psychedelic therapies for psychological well being,” stated Lisa Eire, president and CEO of the Longevity Science Basis. “We’re proud to announce this funding name to help visionaries and researchers devoted to increasing our understanding of psychedelics. We encourage others to be taught extra about this rising discipline.”
“PsyMed has been lively within the psychedelics house for a number of years, partnering with over 13 corporations within the discipline,” stated Matias Serebrinsky, co-founder and normal associate at PsyMed Ventures. “We’re thrilled to work with the LSF to discover new functions of those life-changing compounds and their advantages for human longevity.”
Purposes for this funding name are accepted on a rolling foundation till April 30, 2023. To use, go to https://longevity.foundation/apply.
Press Contact
Rachel Pipan, +31 06 422 13615, [email protected]
In regards to the Longevity Science Basis
The Longevity Science Basis is a nonprofit group advancing human longevity by funding analysis and improvement of medical applied sciences to increase the wholesome human lifespan. The long-term mission of the Longevity Science Basis is to assist make longevity-focused care accessible to everybody, irrespective of their background, by bringing cutting-edge science on getting old out of the laboratory and into the mainstream. To be taught extra, go to www.longevity.foundation.
About PsyMed Ventures
PsyMed Ventures is an early-stage fund investing in psychedelic medication and frontier psychological well being applied sciences. The community-focused fund offers capital and help to the perfect and most modern corporations that align therapeutic, accountability and profitability. Its funding focus spans psychedelics and new compounds, neurotech and brain-computer interfaces, precision psychiatry and digital therapeutics. To be taught extra, go to https://psymed.ventures.
This publication is sponsored. Cointelegraph doesn’t endorse and isn’t accountable for or chargeable for any content material, accuracy, high quality, promoting, merchandise, or different supplies on this web page. Readers ought to do their very own analysis earlier than taking any actions associated to the corporate. Cointelegraph isn’t accountable, immediately or not directly, for any injury or loss brought on or alleged to be attributable to or in reference to using or reliance on any content material, items, or providers talked about within the press launch.
[ad_2]
Source link